Phase II study of gemcitabine (G) in combination with docetaxel (D) in advanced non-small-cell lung cancer (NSCLC) patients.: (Oncopaz and Hospitals Associated).

被引：0
|
作者：
García, C
Milla, A
Feliu, J
Lorenzo, A
Madroñal, C
Gili, F
Baena, JM
机构：
[1] H Gral Yague, Burgos, Spain
[2] Na Sa Pilar, Barcelona, Spain
[3] H La Paz, Madrid, Spain
[4] H Puerto Real, Cadiz, Spain
[5] Clin Corachan, Barcelona, Spain
[6] H Cruz Roja Hosp Llobregat, Barcelona, Spain
[7] H Puerta Mar, Cadiz, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
516P
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer
    T Kurata
    K Tamura
    N Yamamoto
    T Nogami
    T Satoh
    H Kaneda
    K Nakagawa
    M Fukuoka
    British Journal of Cancer, 2004, 90 : 2092 - 2096
  • [32] Combination phase I study of neclaplatin and gemcitabine for advanced non-small-cell lung cancer
    Kurata, T
    Tamura, K
    Yamamoto, N
    Nogami, T
    Satoh, T
    Kaneda, H
    Nakagawa, K
    Fukuoka, M
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2092 - 2096
  • [33] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [36] Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
    Miller, VA
    Krug, LM
    Ng, KK
    Pizzo, B
    Perez, W
    Heelan, RT
    Kris, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1346 - 1350
  • [37] Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):: An AASLC phase II trial
    Krajnik, G
    Mohn-Staudner, A
    Thaler, J
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Malayeri, R
    Schäfer-Prokop, C
    Wein, W
    Huber, H
    Pirker, R
    ANNALS OF ONCOLOGY, 2000, 11 (08) : 993 - 998
  • [38] Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)
    Teixeira, L.
    Descourt, R.
    Moro-Sibilot, D.
    Misset, J. L.
    Gachard, E.
    Rizvi, S.
    Roben, E.
    Zalcman, G.
    EJC SUPPLEMENTS, 2009, 7 (02): : 554 - 554
  • [39] A phase II study of docetaxel and infusional cisplatin in advanced non-small-cell lung cancer
    Mori, K
    Kamiyama, Y
    Kondo, T
    Kano, Y
    Kodama, T
    CHEMOTHERAPY, 2005, 51 (2-3) : 120 - 125
  • [40] Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
    Lippe, P
    Tummarello, D
    Monterubbianesi, MC
    Silva, RR
    Giuliodori, L
    Mari, D
    Santo, A
    Pasini, E
    Cetto, GL
    Rossi, D
    Porfiri, E
    Cascinu, S
    Cellerino, R
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 217 - 221
12345